NCT07125872Phase 2Recruiting

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

Study sponsor: ImmunityBio, Inc. · IBRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05-25Estimated
Enrollment · participants20Estimated
Source updated2026-05-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source